Skip to content
Department of Health and Human Services

FDA Licensed Smallpox Vaccines

Solicitation: BARDA-CBRN-01262026
Notice ID: dc24953fa9a94f6cb8931db735c92fda

Sources Sought from OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE • HEALTH AND HUMAN SERVICES, DEPARTMENT OF. Place of performance: DC. Response deadline: Feb 16, 2026. Industry: PSC 6505.

Market snapshot

Baseline awarded-market signal across all contracting (sample of 400 recent awards; refreshed periodically).

12-month awarded value
$546,655,675
Sector total $546,655,675 • Share 100.0%
Live
Median
$97,181
P10–P90
$33,967$992,402
Volatility
Volatile200%
Market composition
NAICS share of sector
A simple concentration signal, not a forecast.
100.0%
share
Momentum (last 3 vs prior 3 buckets)
+100%($546,655,675)
Deal sizing
$97,181 median
Use as a pricing centerline.
Live signal is computed from awarded notices already observed in the system.
Signals shown are descriptive of observed awards; not a forecast.

Related hubs & trends

Navigate the lattice: hubs for browsing, trends for pricing signals.

We write these bids →
Open on SAM.gov →
Map for DC
Live POP
Place of performance
Not listed
State: DC
Contracting office
Washington, DC • 20515 USA

Point of Contact

Name
Yifan Yang
Email
yifan.yang@hhs.gov
Phone
Not available
Name
Jonathan Gonzalez, Contracting Officer
Email
Jonathan.Gonzalez@hhs.gov
Phone
Not available

Agency & Office

Department
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Agency
OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Subagency
BARDA - ASPR / DAAPPO / BARDA DCMA
Office
Not available
Contracting Office Address
Washington, DC
20515 USA

Description

The Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), is issuing this SSN to collect feedback from current and potential biopharmaceutical partners. Information collected from this SSN will serve as continued market research for possible future acquisitions and programs.

Files

Files size/type shown when available.

BidPulsar Analysis

A practical, capture-style breakdown of fit, requirements, risks, and next steps.

Updated: Feb 14, 2026
Executive summary

The FDA Licensed Smallpox Vaccines opportunity is issued as a Sources Sought Notice by the Biomedical Advanced Research and Development Authority (BARDA) on January 26, 2026. This initiative aims to gather feedback from potential biopharmaceutical partners for future acquisitions related to smallpox vaccines. Responses are due by February 16, 2026, making timely engagement critical for interested parties.

What the buyer is trying to do

BARDA is conducting market research to assess interest and capabilities of biopharmaceutical partners in the development and provision of licensed smallpox vaccines.

Work breakdown
  • Review of technical capabilities
  • Assessment of production timelines
  • Discussion of pricing models
  • Evaluation of regulatory compliance requirements
Response package checklist
  • Statement of capabilities
  • Past performance references
  • Relevant experience in vaccine production
  • Compliance certifications
Suggested keywords
smallpox vaccineBARDAbiopharmaceutical partnersFDA licensed vaccinessources sought
Source coverage notes

Some notices publish limited source detail. Confirm these points before final bid/no-bid decisions.

  • Specific evaluation criteria for submissions is unclear
  • Details on expected contract sizes or funding levels are not provided
  • Clarification on the potential for follow-up solicitations is missing
  • No guidance on how feedback will influence future procurements is included
  • Insufficient detail on performance requirements or metrics
  • Lack of information on historical spending in this area
  • No timeline provided for future decision-making based on this notice

FAQ

How do I use the Market Snapshot?

It summarizes awarded-contract behavior for the opportunity’s NAICS and sector, including a recent pricing band (P10–P90), momentum, and composition. Use it as context, not a guarantee.

Is the data live?

The signal updates as new awarded notices enter the system. Always validate the official award and solicitation details on SAM.gov.

What do P10 and P90 mean?

P10 is the 10th percentile award size and P90 is the 90th percentile. Together they describe the typical spread of award values.